Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Recher

Showing results (411-420 of 488) with videos related to

Pageof 49
Sort By:
Blood Cancer Journal|March 29, 2025
Venetoclax and azacitidine in untreated patients with therapy-related acute myeloid leukemia, antecedent myelodysplastic syndromes or chronic myelomonocytic leukemiaVinod Pullarkat, Keith W Pratz, Hartmut Döhner, et al.
Blood|August 11, 2011
Molecular predictors of response to decitabine in advanced chronic myelomonocytic leukemia: a phase 2 trialThorsten Braun, Raphael Itzykson, Aline Renneville, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 16, 2012
Clofarabine plus cytarabine compared with cytarabine alone in older patients with relapsed or refractory acute myelogenous leukemia: results from the CLASSIC I TrialStefan Faderl, Meir Wetzler, David Rizzieri, et al.
AIDS (London, England)|September 20, 2017
Outcomes for HIV-associated diffuse large B-cell lymphoma in the modern combined antiretroviral therapy eraCaroline Besson, Remi Lancar, Sophie Prevot, et al.
Cancer Medicine|August 24, 2021
Improved survival with enasidenib versus standard of care in relapsed/refractory acute myeloid leukemia associated with IDH2 mutations using historical data and propensity score matching analysisStéphane de Botton, Joseph M Brandwein, Andrew H Wei, et al.
Blood|July 19, 2015
Targeting glutaminolysis has antileukemic activity in acute myeloid leukemia and synergizes with BCL-2 inhibitionNathalie Jacque, Anne Marie Ronchetti, Clément Larrue, et al.
Frontiers in Cellular and Infection Microbiology|March 3, 2020
NK Cells Regulate CD8<sup>+</sup> T Cell Mediated AutoimmunityPhilipp A Lang, Sarah Q Crome, Haifeng C Xu, et al.
Nature Immunology|November 22, 2011
Enforced viral replication activates adaptive immunity and is essential for the control of a cytopathic virusNadine Honke, Namir Shaabani, Giuseppe Cadeddu, et al.
Blood|April 7, 2006
Rapamycin inhibits growth and survival of D816V-mutated c-kit mast cellsMarion Gabillot-Carré, Yves Lepelletier, Martine Humbert, et al.
Cell Death and Differentiation|January 19, 2013
Reactive oxygen species delay control of lymphocytic choriomeningitis virusP A Lang, H C Xu, M Grusdat, et al.
Pageof 49

Showing results (411-420 of 488) with videos related to

Sort By:
Pageof 49
Blood Cancer Journal|March 29, 2025
Venetoclax and azacitidine in untreated patients with therapy-related acute myeloid leukemia, antecedent myelodysplastic syndromes or chronic myelomonocytic leukemiaVinod Pullarkat, Keith W Pratz, Hartmut Döhner, et al.
Blood|August 11, 2011
Molecular predictors of response to decitabine in advanced chronic myelomonocytic leukemia: a phase 2 trialThorsten Braun, Raphael Itzykson, Aline Renneville, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 16, 2012
Clofarabine plus cytarabine compared with cytarabine alone in older patients with relapsed or refractory acute myelogenous leukemia: results from the CLASSIC I TrialStefan Faderl, Meir Wetzler, David Rizzieri, et al.
AIDS (London, England)|September 20, 2017
Outcomes for HIV-associated diffuse large B-cell lymphoma in the modern combined antiretroviral therapy eraCaroline Besson, Remi Lancar, Sophie Prevot, et al.
Cancer Medicine|August 24, 2021
Improved survival with enasidenib versus standard of care in relapsed/refractory acute myeloid leukemia associated with IDH2 mutations using historical data and propensity score matching analysisStéphane de Botton, Joseph M Brandwein, Andrew H Wei, et al.
Blood|July 19, 2015
Targeting glutaminolysis has antileukemic activity in acute myeloid leukemia and synergizes with BCL-2 inhibitionNathalie Jacque, Anne Marie Ronchetti, Clément Larrue, et al.
Frontiers in Cellular and Infection Microbiology|March 3, 2020
NK Cells Regulate CD8<sup>+</sup> T Cell Mediated AutoimmunityPhilipp A Lang, Sarah Q Crome, Haifeng C Xu, et al.
Nature Immunology|November 22, 2011
Enforced viral replication activates adaptive immunity and is essential for the control of a cytopathic virusNadine Honke, Namir Shaabani, Giuseppe Cadeddu, et al.
Blood|April 7, 2006
Rapamycin inhibits growth and survival of D816V-mutated c-kit mast cellsMarion Gabillot-Carré, Yves Lepelletier, Martine Humbert, et al.
Cell Death and Differentiation|January 19, 2013
Reactive oxygen species delay control of lymphocytic choriomeningitis virusP A Lang, H C Xu, M Grusdat, et al.
Pageof 49